Fred Schwarzer - 18 Apr 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role: CEO and President, Director
Signature: /s/ Fred Schwarzer
Issuer symbol: IGMS
Transactions as of: 18 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 20 Apr 2023, 20:55:57 UTC
Previous filing: 06 Apr 2023
Next filing: 25 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IGMS	Common Stock	Award	$0	+34,200	+39%	$0.000000	122,060	18 Apr 2023	Direct	F1
holding	IGMS	Common Stock						196,718	18 Apr 2023	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units (RSUs), granted pursuant to the election by the Reporting Person to receive RSUs in lieu of an earned cash bonus for performance in fiscal year 2022. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2023, provided that the Reporting Person remains a service provider through the vesting date.
F2	The shares are held by Fred M. Schwarzer & Deborah R. Schwarzer TTEES of the Schwarzer Family Trust U/A DTD 04/05/2018.

Content

These securities are restricted stock units (RSUs), granted pursuant to the election by the Reporting Person to receive RSUs in lieu of an earned cash bonus for performance in fiscal year 2022. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2023, provided that the Reporting Person remains a service provider through the vesting date.

The shares are held by Fred M. Schwarzer & Deborah R. Schwarzer TTEES of the Schwarzer Family Trust U/A DTD 04/05/2018.